Skip to main content
Menu

HTRF Human IL-21 Detection Kit, 500 Assay Points

The HTRF Human IL-21 detection kit is an immunoassay developed for the simple, rapid detection and quantification of soluble human IL-21 protein in cell supernatant, in a homogeneous (no wash steps, no separation steps) format.

Feature Specification
Application Protein Quantification
Dynamic Range 82,9-2000 pg/mL
Limit of Detection 8 pg/mL
Limit of Quantification 37 pg/mL
Sample Volume 14 µL

The HTRF Human IL-21 detection kit is an immunoassay developed for the simple, rapid detection and quantification of soluble human IL-21 protein in cell supernatant, in a homogeneous (no wash steps, no separation steps) format.

Product variants
Compare all
Remove all
Add to compare Add to compare
Remove
Unit Size: 500 Assay Points
Part #:
62HIL21PEG
List price
USD 1,208.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 10,000 Assay Points
Part #:
62HIL21PEH
List price
USD 11,265.00
Your price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Loading...

Overview

IL-21 (interleukin-21) is a type I cytokine belonging to the common gamma chain cytokine family. It is mainly produced by activated CD4⁺ T cells, particularly T follicular helper and Th17 subsets. IL-21 signals through a heterodimeric receptor and activates JAK1 and JAK3, leading to phosphorylation and activation of STAT3. IL-21 exerts a broad range of immune-modulatory effects on T cells, B cells, NK cells, dendritic cells, and macrophages, making it a central player in immune regulation, inflammation, and tumor immunity.

 HTRF assays offer many advantages over other technologies:

  • Homogeneous add-and-read format
  • No wash steps
  • Low background
  • Straightforward miniaturization from 96- or 384-well microplates to high density assay formats such as 384-well low volume and 1536-well plates
  • Stable signal, providing flexibility in readout time or assay size

How it works

Principle of the HTRF human IL-21 assay

The HTRF human IL-21 assay is based on a TR-FRET sandwich immunoassay involving two specific antibodies, one labelled with Eu3+-cryptate (donor) and the other with d2 (acceptor). Both antibodies bind to soluble human IL-21, and the donor-acceptor proximity leads to a fluorescent TR-FRET signal. The intensity of the signal is directly proportional to the concentration of soluble IL-21 present in the sample.

Assay principle HTRF IL-21 kit

Protocol of the HTRF human IL-21 assay

The HTRF human IL-21 assay can be run in a 96- or 384-well low volume white detection plate (20 µL final). As shown here, samples or standards are dispensed directly into the assay plate for the detection of IL-21 by HTRF reagents. The antibodies labelled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.

Protocol of the HTRF Human IL-21 assay

Assay details

Sample size 14 µL
Final assay volume 20 µL
Kit component Lyophilized standard, frozen detection antibodies & buffers
LOD & LOQ (in Diluent) 8 & 37 pg/mL
LOD & LOQ (in RPMI) 9 & 51 pg/mL
LOD & LOQ (in DMEM) 13 & 43 pg/mL
Range 82.9 - 2000 pg/mL
Time to result 3h at RT
Species Human

Analytical performance

Intra-assay precision table

Each of the 3 samples was measured 24 times, and the %CV was calculated for each sample. Samples were human recombinant IL-21.

Sample Mean [IL-21] pg/ml CV
1 180 10%
2 463 13%
3 1541 13%
  Mean CV 12%

Inter-assay precision table

Each of the samples was measured in 3 independent experiments (3 separate days), and the %CV was calculated for each sample. Samples were human recombinant IL-21.

Sample Mean [IL-21] pg/ml CV
1 280 3%
2 579 7%
3 1648 1%
  Mean CV 4%

Dilution linearity

The recovery percentages obtained from these experiments show the good dilution linearity of the assay. Human recombinant IL-21 was diluted in RPMI cell medium.

Dilution factor Expected [IL-21] pg/mL Measured [IL-21] pg/mL % dilution recovery
Neat 1097 1097 100%
2 548 608 111%
4 274 300 109%
8 137 160 117%
16 69 78 113%

 

Spike and recovery

A known amount of recombinant IL-21 was spiked into a dilution of supernatant from PBMC culture medium stimulated with PMA and ionomycin. The expected concentrations were compared to those measured in order to compute antigen recoveries (acceptance criteria: 80-120%). A 100% recovery indicates similar measurements of cytokine from a sample and the kit standard.

Standard [IL-21] pg/mL Native [IL-21] pg/mL Expected [IL-21] pg/mL Obtained [IL-21] pg/mL Recovery %
213 0 213 204 96%
213 100 313 295 94%
213 193 406 392 97%
213 606 819 790 96%
213 975 1188 1160 98%

 

Cross-reactivity

Cross reactivities were assessed using recombinant proteins tested at a concentration of 2000 pg/mL. Signals were interpolated on the assay standard curve to calculate concentrations. The assay is only compatible with human IL-21.

Tested protein Cross reactivity
Human IL-21 100%
Mouse IL-21 0%

Assay validation

Validation of HTRF human IL-21 detection kit on PBMC cell supernatant

Human PBMCs (peripheral blood mononuclear cells) were seeded at 100,000 to 800,000 cells in a 96-well culture-treated plate in RPMI + 10% FBS medium, and stimulated with PMA (50ng/mL) and ionomycin (1µg/mL) for 48 hours at 37°C. Then 14 µL of supernatant were transferred into a white detection plate and 2 µL of activation reagent-2 and 4 µL of the pre-mixed HTRF IL-21 detection reagents were added. The HTRF signal was recorded after 3 hours of incubation at room temperature. The standard curve prepared in RPMI + 10% FBS allowed the interpolation of the human IL-21 concentration in each sample.

Validation of HTRF human IL-21 detection kit on PBMC cell supernatant

Validation of HTRF human IL-21 detection on PMA and ionomycin treated PBMC cells

Human PBMC cells were seeded at 400,000 cells in a 96-well culture-treated plate in RPMI + 10% FBS culture medium and stimulated with increasing concentrations of PMA and Ionomycin for 48 hours at 37°C. Then 14 µL of supernatant were transferred into a white detection plate and 2 µL of activation reagent 2 and 4 µL of the pre-mixed HTRF IL-21 detection reagents were added. The HTRF signal was recorded after 3 hours of incubation at room temperature. The standard curve prepared in RPMI + 10% FBS allowed the interpolation of the human IL-21 concentration in each sample.

Validation of HTRF human IL-21 detection on PMA and Ionomycin treated PBMC cells

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
HTRF
Detection Modality
HTRF
Dynamic Range
82,9-2000 pg/mL
Limit of Detection
8 pg/mL
Limit of Quantification
37 pg/mL
Product Group
Kit
Sample Volume
14 µL
Shipping Conditions
Shipped in Dry Ice
Target
IL-21
Target Class
Cytokine
Target Species
Human
Technology
TR-FRET
Unit Size
500 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

Loading...

Revvity AI Assistant Beta

Scroll Icon